People (much more often women) have acute attacks of symptoms that stop, and a person recovers partially or completely until ...

One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be impacted has been mostly invisible to ...

Changes in the upper spinal cord, measured on routine brain MRI, may help flag higher MS progression risk in people with RRMS ...

A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B ...

A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a low ...

Detailed price information for Tiziana Life Sciences Ltd (TLSA-Q) from The Globe and Mail including charting and trades.

Provides broad overview of Company's research and early development programs expected to continue to fuel future growthHighlights validation of T-cell engager modality with mRNA-2808 in multiple myelo ...

Provides broad overview of Company's research and early development programs expected to continue to fuel future growth ...

Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. An announcement from Sanofi ( (SNY)) is now available. In June 2026, Sanofi reported a series of ...

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...

eMultiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, ...